Literature DB >> 25025999

Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.

Peter M Petersen1, Marianne C Aznar, Anne K Berthelsen, Annika Loft, Deborah A Schut, Maja Maraldo, Mirjana Josipovic, Thomas L Klausen, Flemming L Andersen, Lena Specht.   

Abstract

BACKGROUND: Long-term Hodgkin lymphoma (HL) survivors have an increased risk of late cardiac morbidity and secondary lung cancer after chemotherapy and mediastinal radiotherapy. In this prospective study we investigate whether radiotherapy with deep inspiration breath-hold (DIBH) can reduce radiation doses to the lungs, heart, and cardiac structures without compromising the target dose. PATIENTS AND METHODS: Twenty-two patients (14 female, 8 male), median age 30 years (18-65 years), with supra-diaphragmatic HL were enrolled and had a thoracic PET/CT with DIBH in addition to staging FDG-PET/CT in free breathing (FB) and a planning CT in both FB and DIBH. For each patient an involved-node radiotherapy plan was done for both DIBH and FB, and the doses to the lungs, heart, and female breasts were recorded prospectively. Mean doses to the heart valves and coronary arteries were recorded retrospectively. Patients were treated with the technique yielding the lowest doses to normal structures.
RESULTS: Nineteen patients were treated with DIBH and three with FB. DIBH reduced the mean estimated lung dose by 2.0 Gy (median: 8.5 Gy vs. 7.2 Gy) (p < 0.01) and the mean heart dose by 1.4 Gy (6.0 Gy vs. 3.9 Gy) (p < 0.01) compared to FB. The lung and heart V20Gy were reduced with a median of 5.3% and 6.3%. Mean doses to the female breasts were equal with FB and DIBH.
CONCLUSION: DIBH can significantly decrease the estimated mean doses to the heart and lungs without lowering the dose to the target in radiotherapy for patients with mediastinal HL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25025999     DOI: 10.3109/0284186X.2014.932435

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  23 in total

Review 1.  The concept and evolution of involved site radiation therapy for lymphoma.

Authors:  Lena Specht; Joachim Yahalom
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

2.  Comparing Breath Hold and Free Breathing during Intensity-Modulated Radiation Therapy and Proton Therapy in Patients with Mediastinal Hodgkin Lymphoma.

Authors:  Bradford S Hoppe; Nancy P Mendenhall; Debbie Louis; Zuofeng Li; Stella Flampouri
Journal:  Int J Part Ther       Date:  2017-07-11

Review 3.  Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.

Authors:  Andrea Riccardo Filippi; Mario Levis; Rahul Parikh; Bradford Hoppe
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

Review 4.  Radiation-Associated Pericardial Disease.

Authors:  Natalie Szpakowski; Milind Y Desai
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 5.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

6.  Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.

Authors:  Chelsea C Pinnix; Grace L Smith; Sarah Milgrom; Eleanor M Osborne; Jay P Reddy; Mani Akhtari; Valerie Reed; Isidora Arzu; Pamela K Allen; Christine F Wogan; Michele A Fanale; Yasuhiro Oki; Francesco Turturro; Jorge Romaguera; Luis Fayad; Nathan Fowler; Jason Westin; Loretta Nastoupil; Fredrick B Hagemeister; M Alma Rodriguez; Sairah Ahmed; Yago Nieto; Bouthaina Dabaja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

Review 7.  Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?

Authors:  Jesse Caron; Anju Nohria
Journal:  Curr Oncol Rep       Date:  2018-06-06       Impact factor: 5.075

8.  Electrocardiogram-Gated Computed Tomography with Coronary Angiography for Cardiac Substructure Delineation and Sparing in Patients with Mediastinal Lymphomas Treated with Radiation Therapy.

Authors:  Scott C Lester; Kekoa Taparra; Molly M Petersen; Ryan K Funk; Miran J Blanchard; Phillip M Young; Joerg Herrmann; Ashley E Hunzeker; Heather L Schultz; Cynthia McCollough; Alexandria M Tasson; Shuai Leng; James A Martenson; Amanda J Deisher; Thomas J Whitaker; Eric E Williamson; Nadia N Laack
Journal:  Pract Radiat Oncol       Date:  2019-11-26

9.  Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trial.

Authors:  Mirjana Josipovic; Marianne C Aznar; Jakob B Thomsen; Jonas Scherman; Sidsel Ms Damkjaer; Lotte Nygård; Lena Specht; Mette Pøhl; Gitte F Persson
Journal:  Br J Radiol       Date:  2019-09-26       Impact factor: 3.039

Review 10.  Cardiotoxicity of mediastinal radiotherapy.

Authors:  Ivica Ratosa; Maja Ivanetic Pantar
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.